This Technical Specification does not address supplements (e.g. blood or blood products) that are added to the medium to support growth of fastidious bacteria[3][4][5][6]. Those additives are provided after the dehydrated medium is prepared in its liquid state as a final product and fall outside of the scope of this Technical Specification. Although dMHA can be used for determination of MICs using the agar dilution method[4][6] or the gradient diffusion method, this Technical Specification only includes performance testing of dMHA using disc diffusion methodology as described by the Clinical and Laboratory Standards Institute (CLSI)[5] and European Committee on Antimicrobial Susceptibility Testing (EUCAST)[3].
Cross References:
ISO 20776-1:2006
CLSI M100
NCCLS M32-P:2001
CLSI M6-A2:2006
CLSI M02-A12:2015
CLSI M07-A10:2015
CLSI M100S:2016
All current amendments available at time of purchase are included with the purchase of this document.